Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials

Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression

To see complete record on, please visit this link

Id: NCT03715127

Organisation Name: University of Zurich

Overal Status: Completed

Start Date: March 11, 2019

Last Update: April 29, 2022

Lead Sponsor: University of Zurich

Brief Summary: Effects of serotonin 2A/1A receptor stimulation by psilocybin on mood and emotion processing in major depressive disorder: a randomized double-blind placebo-controlled study

  • Depressive Disorder, Major

Total execution time in seconds: 0.20306301116943